NCT06382987 A Study of the Comparative Effectiveness of Deucravacitinib in Adults With Plaque Psoriasis in Japan (RePhlect) Status RECRUITING Phase N/A
NCT06333860 A Study to Learn How Safe and Effective Risankizumab is When Compared to Deucravacitinib to Treat Participants With Moderate Plaque Psoriasis and Who Need to Try Systemic Treatment (Works Throughout the Whole Body) Status COMPLETED Phase PHASE4
NCT06327321 Vitiligo Treatment by Targeting TYK2 Mediated Responses Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06258668 Real-World Safety and Effectiveness of Sotyktu (Deucravacitinib) in Patients With Moderate-to-Severe Plaque Psoriasis in Korea Status RECRUITING Phase N/A
NCT06220604 A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (ICONIC-ADVANCE 2) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06143878 A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06136403 A 44-week Monocentric Open Study Assessing the Efficacy and Safety of Deucravacitinib in Adults With Inflammatory Genodermatoses Status RECRUITING Phase PHASE2
NCT06104644 A Study to Evaluate Deucravacitinib in Participants With Moderate-to-Severe Plaque Psoriasis in Germany Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06042920 A Study to Evaluate Effectiveness and Safety of Deucravacitinib in Participants With Non-Pustular Palmoplantar and Genital Psoriasis Status TERMINATED Phase PHASE4
NCT05997277 Evaluating the Safety and Efficacy of Deucravacitinib Compared to Placebo Hidradenitis Suppurativa (HS). Status TERMINATED Phase PHASE2
NCT05946941 A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05858645 Correction of Psoriatic T Cell Signatures by Deucravacitinib Status RECRUITING Phase PHASE4
NCT05744466 A Real-world Observational Study to Compare Effectiveness of Deucravacitinib Vs Apremilast in Adults With Plaque Psoriasis Status RECRUITING Phase N/A
NCT05710185 Deucravacitinib for the Treatment of Palmoplantar Pustulosis Status TERMINATED Phase PHASE4
NCT05701995 A Study to Evaluate the Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting Status COMPLETED Phase PHASE4